Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Early interventions to prevent psychosis: systematic review and meta-analysis.

Stafford MR, Jackson H, Mayo-Wilson E, Morrison AP, Kendall T.

BMJ. 2013 Jan 18;346:f185. doi: 10.1136/bmj.f185. Review. Erratum in: BMJ. 2013;346:f762.

2.

Efficacy and safety of pharmacological and psychological interventions for the treatment of psychosis and schizophrenia in children, adolescents and young adults: a systematic review and meta-analysis.

Stafford MR, Mayo-Wilson E, Loucas CE, James A, Hollis C, Birchwood M, Kendall T.

PLoS One. 2015 Feb 11;10(2):e0117166. doi: 10.1371/journal.pone.0117166. eCollection 2015. Review.

3.

Early intervention for psychosis.

Marshall M, Rathbone J.

Cochrane Database Syst Rev. 2011 Jun 15;(6):CD004718. doi: 10.1002/14651858.CD004718.pub3. Review.

4.

Early intervention for psychosis.

Marshall M, Rathbone J.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004718. Review. Update in: Cochrane Database Syst Rev. 2011;(6):CD004718.

PMID:
17054213
5.

Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults.

van Dessel N, den Boeft M, van der Wouden JC, Kleinstäuber M, Leone SS, Terluin B, Numans ME, van der Horst HE, van Marwijk H.

Cochrane Database Syst Rev. 2014 Nov 1;(11):CD011142. doi: 10.1002/14651858.CD011142.pub2. Review.

PMID:
25362239
6.

Primary prevention of psychosis through interventions in the symptomatic prodromal phase, a pragmatic Norwegian Ultra High Risk study.

Joa I, Gisselgård J, Brønnick K, McGlashan T, Johannessen JO.

BMC Psychiatry. 2015 Apr 22;15:89. doi: 10.1186/s12888-015-0470-5.

7.

Atypical antipsychotics for psychosis in adolescents.

Kumar A, Datta SS, Wright SD, Furtado VA, Russell PS.

Cochrane Database Syst Rev. 2013 Oct 15;(10):CD009582. doi: 10.1002/14651858.CD009582.pub2. Review.

PMID:
24129841
8.

Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.

Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML, Christiaens T.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD007726. doi: 10.1002/14651858.CD007726.pub2. Review.

PMID:
23543555
9.

Psychological, social and welfare interventions for psychological health and well-being of torture survivors.

Patel N, Kellezi B, Williams AC.

Cochrane Database Syst Rev. 2014 Nov 11;(11):CD009317. doi: 10.1002/14651858.CD009317.pub2. Review.

PMID:
25386846
10.

Early psychotic experiences: Interventions, problems and perspectives.

Dimitrakopoulos S, Kollias C, Stefanis NC, Kontaxakis V.

Psychiatriki. 2015 Jan-Mar;26(1):45-54. Review.

PMID:
25880383
11.

Intervention in individuals at ultra-high risk for psychosis: a review and future directions.

McGorry PD, Nelson B, Amminger GP, Bechdolf A, Francey SM, Berger G, Riecher-Rössler A, Klosterkötter J, Ruhrmann S, Schultze-Lutter F, Nordentoft M, Hickie I, McGuire P, Berk M, Chen EY, Keshavan MS, Yung AR.

J Clin Psychiatry. 2009 Sep;70(9):1206-12. doi: 10.4088/JCP.08r04472. Epub 2009 Jun 30. Review.

PMID:
19573499
12.

[Psychosis prevention: expectations met].

Bechdolf A, Peukert R.

Psychiatr Prax. 2011 Feb;38(2):58-60. doi: 10.1055/s-0030-1266056. Epub 2011 Mar 10. German. No abstract available.

PMID:
21394689
13.

Pharmacological interventions for somatoform disorders in adults.

Kleinstäuber M, Witthöft M, Steffanowski A, van Marwijk H, Hiller W, Lambert MJ.

Cochrane Database Syst Rev. 2014 Nov 7;(11):CD010628. doi: 10.1002/14651858.CD010628.pub2. Review.

PMID:
25379990
14.

Training to recognise the early signs of recurrence in schizophrenia.

Morriss R, Vinjamuri I, Faizal MA, Bolton CA, McCarthy JP.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD005147. doi: 10.1002/14651858.CD005147.pub2. Review.

PMID:
23450559
15.

Omega-3 fatty acids for the treatment of dementia.

Burckhardt M, Herke M, Wustmann T, Watzke S, Langer G, Fink A.

Cochrane Database Syst Rev. 2016 Apr 11;4:CD009002. doi: 10.1002/14651858.CD009002.pub3. Review.

PMID:
27063583
16.

Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

Amminger GP, Schäfer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, Mackinnon A, McGorry PD, Berger GE.

Arch Gen Psychiatry. 2010 Feb;67(2):146-54. doi: 10.1001/archgenpsychiatry.2009.192.

PMID:
20124114
17.

Cannabis and schizophrenia.

McLoughlin BC, Pushpa-Rajah JA, Gillies D, Rathbone J, Variend H, Kalakouti E, Kyprianou K.

Cochrane Database Syst Rev. 2014 Oct 14;(10):CD004837. doi: 10.1002/14651858.CD004837.pub3. Review.

PMID:
25314586
18.

Adolescents and young adults at ultrahigh risk of psychosis: detection, prediction and treatment. A review of current knowledge.

Mees L, Zdanowicz N, Reynaert C, Jacques D.

Psychiatr Danub. 2011 Sep;23 Suppl 1:S118-22. Review.

PMID:
21894117
19.

[Interventions in people at risk of developing first episode psychosis: a survey of current randomised controlled studies].

Müller H, Wießmann T, Bechdolf A.

Fortschr Neurol Psychiatr. 2012 Oct;80(10):570-9. doi: 10.1055/s-0032-1313038. Epub 2012 Oct 2. Review. German.

PMID:
23033203
20.

Psychosocial interventions for men with prostate cancer.

Parahoo K, McDonough S, McCaughan E, Noyes J, Semple C, Halstead EJ, Neuberger MM, Dahm P.

Cochrane Database Syst Rev. 2013 Dec 24;(12):CD008529. doi: 10.1002/14651858.CD008529.pub3. Review.

PMID:
24368598

Supplemental Content

Support Center